Masume Behruzi

Masume Behruzi

Auto-generated profile, based on publicly available information

Masume Behruzi

Department of Anatomical Sciences, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2025 in Basic and Clinical Neuroscience Journal
Verified
Journal Article
Open access
PDF file
MBMasume Behruzi
Masume Behruzi
MGMehrdad Ghorbanlou
Mehrdad Ghorbanlou
RSRonak Shabani
Ronak Shabani
ARAoub Rustamzadeh
Aoub Rustamzadeh
EGEnam Alhagh Charkhat Gorgich
Enam Alhagh Charkhat Gorgich
FMFatemeh Moradi
Fatemeh Moradi
Introduction: Targeting smoothened (SMO) has been a remarkable strategy for treating sonic hedgehog (Shh)-dependent cancers, especially medulloblastoma. GDC-0449, also known as vismodegib, is a potent SMO inhibitor with mild toxicity and high affinity. Thus, this study aimed to investigate the anti-medulloblastoma efficacy of vismodegib in the DAOY medulloblastoma cell line. Methods: Human ...

1 March 2025 in Physiology and Pharmacology
Verified
Journal Article
Open access
PDF file
SDShahram Darabi
Shahram Darabi
AAArmin Ariaei
Armin Ariaei
EGEnam Alhagh Charkhat Gorgich
Enam Alhagh Charkhat Gorgich
SRShohreh Rezaei
Shohreh Rezaei
MBMasume Behruzi
Masume Behruzi
ARAuob Rustamzadeh
Auob Rustamzadeh
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder with a high prevalence worldwide. It is associated with annoying and debilitating cognitive and memory deficits. For many years, various herbs have been consumed to boost memory and other dementia-related complications. Acetylcholinesterase (AChE) inhibitory, antioxidant properties, and neuroprotective effects of medicinal plants have broadened ...